Other languages CombiGene AB

Equities

COMBI

SE0016101935

Market Closed - Nasdaq Stockholm Other stock markets 11:13:30 2024-05-24 am EDT			5-day change	1st Jan Change
3.15 ^SEK	-3.67%		-6.25%	+17.10%

May. 23	CombiGene AB Approves Election of Marcus Isaksson as Board Member	CI
May. 17	CombiGene AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CombiGene AB Approves Election of Marcus Isaksson as Board Member	May. 23
CombiGene AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 17
CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries	Mar. 13
Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI).	Feb. 20
CombiGene AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 16
CombiGene AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10
CombiGene Taps Charles River Laboratories as Clinical Research Partner for Pain Project	Nov. 01
Combigene AB Chooses Charles River as Preclinical Toxicology Partner for COZY01 Pain Project	23-10-31
CombiGene AB and Zyneyro Choose Initial Indication in the Cozy01 Pain Project	23-10-26
Spark Therapeutics Terminates Collaboration Agreement for the Epilepsy Project CG01 with CombiGene AB	23-10-14
CombiGene AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25
CombiGene AB Announces Chief Executive Officer Changes	23-06-30
Combigene AB to Play an Integrate Part in the Development of National Infrastructure for ATMPs	23-05-24
CombiGene AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
CombiGene AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-17
Combigene Enters into Collaboration Agreement with Zyneyro for the Development of A Unique Concept for Effective Relief of Chronic Pain	23-01-09
CombiGene AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11
Combigene AB Appoints Peter Ekolind as COO	22-09-27
CombiGene AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25
CombiGene AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CombiGene AB

Equities

COMBI

SE0016101935

Other languages

Filters